Antibodies reactive against antigenic domain 4 (AD4) (amino acids 121-132 and 344-438) of CMV AD169 envelope glycoprotein B (gB) were isolated from the plasma of a healthy volunteer having CMV- neutralizing activity. The anti-human cytomegalovirus antibody (C6) has high affinity to CMV with KD value of 0.25 nM. The IC₅₀ value of neutralizing activity is less than 2 μg/ml. It can be used in the research of treatment, prophylaxis, detection, and diagnosis of human cytomegalovirus infection.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-2-sdAb | Recombinant Anti-CMV VHH Single Domain Antibody | IHC, IP, FC, Neut, FUNC | Llama VHH |
There are currently no Customer reviews or questions for HPAB-AP307-YC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.